M T5 (Trifluoperazine 5 mg)
Pill imprint M T5 has been identified as Trifluoperazine hydrochloride 5 mg.
Trifluoperazine is used in the treatment of anxiety; schizophrenia and belongs to the drug class phenothiazine antipsychotics. FDA has not classified the drug for risk during pregnancy. Trifluoperazine 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- M T5
- 5 mg
- Prescription only
- Drug Class:
- Phenothiazine antipsychotics
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
sodium lauryl sulfate
D&C Red No. 30
FD&C Blue No. 2
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|51079-0574||UDL Laboratories Inc|
More about trifluoperazine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 9 Reviews – Add your own review/rating
- Drug class: phenothiazine antipsychotics
- Trifluoperazine Hydrochloride (AHFS Monograph)
- Trifluoperazine Tablets (FDA)
- Trifluoperazine (Wolters Kluwer)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.